Literature DB >> 18091452

Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).

John L Keltner1, Chris A Johnson, Kimberly E Cello, Shannan E Bandermann, Juanjuan Fan, Richard A Levine, Michael A Kass, Mae O Gordon.   

Abstract

OBJECTIVE: To report the impact of visual field quality control (QC) procedures on the rates of visual field unreliability, test parameter errors, and visual field defects attributed to testing artifacts in the Ocular Hypertension Treatment Study (OHTS).
METHODS: OHTS technicians were certified for perimetry and were required to submit 2 sets of visual fields that met study criteria before testing study participants. The OHTS Visual Field Reading Center (VFRC) evaluated 46,777 visual fields completed by 1618 OHTS participants between February 1994 and December 2003. Visual field QC errors, rates of unreliability, and defects attributed to testing artifacts were assessed. The OHTS QC system addressed 3 areas of clinic performance: (1) test parameter errors, (2) patient data errors, and (3) shipment errors. A visual field was classified as unreliable if any of the reliability indices exceeded the 33% limit. Clinical sites were immediately contacted by the VFRC via fax, e-mail, and/or phone and instructed on how to prevent further testing errors on fields with defects attributed to testing artifacts. MAIN OUTCOME MEASURES: QC errors (test parameter errors) and unreliability rates.
RESULTS: A total of 2.4% (1136/ 46,777) of the visual fields were unreliable and 0.23% (107/46,777) had incorrect test parameters. Visual field defects attributed to testing artifacts occurred in approximately 1% (483/46,777) of the visual fields.
CONCLUSIONS: Prompt transmission of visual fields to the VFRC for ongoing and intensive QC monitoring and rapid feedback to technicians helps to reduce the frequency of unreliable visual fields and incorrect testing parameters. Visual field defects attributed to testing artifacts were infrequent in the OHTS.

Entities:  

Mesh:

Year:  2007        PMID: 18091452     DOI: 10.1097/IJG.0b013e318057526d

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  15 in total

1.  African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes.

Authors:  Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample
Journal:  Arch Ophthalmol       Date:  2010-05

2.  [Current state of pupil-based diagnostics for glaucomatous optic neuropathy].

Authors:  K Skorkovská; U Schiefer; B Wilhelm; H Wilhelm
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

3.  Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mariya Dontchev; Robin L Gal; Roy W Beck
Journal:  Arch Ophthalmol       Date:  2010-03

4.  High myopia as a risk factor in primary open angle glaucoma.

Authors:  Sheng-Ju Chen; Peng Lu; Wen-Fang Zhang; Jian-Hua Lu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

5.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

6.  Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials.

Authors:  John L Keltner; Kimberly E Cello; Laura J Balcer; Peter A Calabresi; Clyde E Markowitz; John S Werner
Journal:  Neuroophthalmology       Date:  2011-03-20

7.  Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.

Authors:  Paul H Artes; Balwantray C Chauhan; John L Keltner; Kim E Cello; Chris A Johnson; Douglas R Anderson; Mae O Gordon; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2010-12

8.  Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project.

Authors:  Pradeep Y Ramulu; Sheila K West; Beatriz Munoz; Henry D Jampel; David S Friedman
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

9.  Glaucoma and reading speed: the Salisbury Eye Evaluation project.

Authors:  Pradeep Y Ramulu; Sheila K West; Beatriz Munoz; Henry D Jampel; David S Friedman
Journal:  Arch Ophthalmol       Date:  2009-01

10.  Objective Assessment of Activity Limitation in Glaucoma with Smartphone Virtual Reality Goggles: A Pilot Study.

Authors:  Rachel L Z Goh; Yu Xiang George Kong; Colm McAlinden; John Liu; Jonathan G Crowston; Simon E Skalicky
Journal:  Transl Vis Sci Technol       Date:  2018-01-23       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.